We are live on
!
Find out more
CS
Cannell & Spears Portfolio holdings
AUM
$5.1B
1-Year Est. Return
31.77%
This Fund
S&P 500
This Quarter
Est. Return
+3.87%
1 Year Est. Return
+31.77%
3 Year Est. Return
+94.5%
5 Year Est. Return
+108.17%
10 Year Est. Return
+357.88%
AUM
$679M
AUM Growth
–
Cap. Flow
+$677M
Cap. Flow
% of AUM
99.7%
Top 10 Holdings %
Top 10 Hldgs %
44.28%
Holding
98
New
98
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chubb
CB
|
+$35.3M |
| 2 |
Oracle
ORCL
|
+$33.2M |
| 3 |
Aon
AON
|
+$31.7M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$31.5M |
| 5 |
United Parcel Service
UPS
|
+$29.9M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.14% |
| 2 | Technology | 16.09% |
| 3 | Industrials | 13.29% |
| 4 | Energy | 12.48% |
| 5 | Healthcare | 11.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Johnson Controls International
JCI
$85.7B
| $11.3M | 1.67% |
+302,148
| New | +$11.3M |
|
27
Carpenter Technology
CRS
$27.7B
| $10.7M | 1.58% |
+238,237
| New | +$11.1M |
|
|
CB
28
DELISTED
CHUBB CORPORATION
CB
| $9.48M | 1.4% |
+112,043
| New | +$9.8M |
|
29
Gilead Sciences
GILD
$167B
| $7.92M | 1.17% |
+154,385
| New | +$8.05M |
|
30
Baxter International
BAX
$11.7B
| $5.96M | 0.88% |
+158,519
| New | +$6.07M |
|
31
Philip Morris
PM
$301B
| $4.57M | 0.67% |
+52,717
| New | +$4.9M |
|
32
Johnson & Johnson
JNJ
$609B
| $4.04M | 0.6% |
+47,084
| New | +$4M |
|
|
AMRN
33
Amarin Corp
AMRN
$292M
| $3.36M | 0.49% |
+28,932
| New | +$3.99M |
|
34
ExxonMobil
XOM
$611B
| $2.67M | 0.39% |
+29,506
| New | +$2.65M |
|
35
Altria Group
MO
$124B
| $2.65M | 0.39% |
+75,642
| New | +$2.72M |
|
|
KMR
36
DELISTED
KINDER MORGAN MANAGEMENT LLC
KMR
| $2.4M | 0.35% |
+31,679
| New | +$2.42M |
|
37
State Street SPDR S&P 500 ETF Trust
SPY
$774B
| $2.28M | 0.34% |
+14,195
| New | +$2.29M |
|
38
Union Bankshares
UNB
$117M
| $2.22M | 0.33% |
+101,973
| New | +$2.16M |
|
39
CVS Health
CVS
$137B
| $1.82M | 0.27% |
+31,900
| New | +$1.85M |
|
40
JPMorgan Chase
JPM
$907B
| $1.76M | 0.26% |
+33,393
| New | +$1.7M |
|
41
Mondelez International
MDLZ
$78.3B
| $1.73M | 0.25% |
+60,483
| New | +$1.84M |
|
42
Biogen
BIIB
$30.4B
| $1.26M | 0.19% |
+5,880
| New | +$1.26M |
|
43
Wells Fargo
WFC
$265B
| $1.14M | 0.17% |
+27,601
| New | +$1.08M |
|
|
KRFT
44
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
| $1.11M | 0.16% |
+19,874
| New | +$1.07M |
|
45
Merck
MRK
$315B
| $1.07M | 0.16% |
+24,218
| New | +$1.08M |
|
46
Crown Castle
CCI
$34.6B
| $1.06M | 0.16% |
+14,625
| New | +$1.07M |
|
47
UnitedHealth
UNH
$387B
| $1.01M | 0.15% |
+15,500
| New | +$964K |
|
48
APA Corp
APA
$12.4B
| $981K | 0.14% |
+11,700
| New | +$930K |
|
49
Markel Group
MKL
$24.7B
| $950K | 0.14% |
+1,803
| New | +$944K |
|
50
Berkshire Hathaway Class A
BRK.A
$1.06T
| $843K | 0.12% |
+5
| New | +$825K |
|
Similar funds
NC
EIC
AC
VT
CIA
TAM
BG
PA
Cannell & Spears's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Cannell & Spears, which disclosed 98 positions worth $679M. Its ten largest holdings account for 44% of the portfolio.
Its largest position is Chubb: 394,185 shares worth $35.3M.
By sector, the portfolio is most concentrated in Financials at 24% of assets, followed by Technology and Industrials.
- Cannell & Spears's largest Q2 2013 buy was Chubb: 394,185 shares worth $35.3M.
- Cannell & Spears's ten largest holdings make up 44% of its $679M portfolio in Q2 2013.
- Cannell & Spears disclosed 98 positions in Q2 2013, its first 13F filing on record.
Based on Cannell & Spears's 13F filing for Q2 2013, filed 14 Aug 2013.